Literature DB >> 19901935

Utility and health-related quality of life in prostate cancer patients 12 months after radical prostatectomy or radiation therapy.

M D Krahn1, K E Bremner, G Tomlinson, G Naglie.   

Abstract

This study aims to examine and compare changes in quality of life after two common treatments for prostate cancer (PC), radical prostatectomy (RP) and radiation therapy (RT). Patients newly diagnosed with localized PC, scheduled to receive RP (n=68) or RT (n=66), completed three cancer/PC-specific psychometric instruments and three PC-specific utility instruments before treatment, and 2 and 12 months after treatment. We assessed the magnitude and time course of changes in psychometric and utility measures, and differences between treatments. The results showed that RP was associated with significant urinary and sexual dysfunction; RT caused bowel problems. Fatigue and pain were common to both. RP patients reported more problems with physical, role and social function. Utilities decreased significantly after both treatments. Effects were most severe 2 months post treatment, and then showed some recovery, but many endured for 1 year. After 1 year, 30-60% of patients had utility scores that were clinically significantly worse than at baseline. Secondary androgen deprivation therapy also significantly decreased psychometric and utility measures of quality of life. Many adverse symptoms reported 2 months after RP and RT endure for 1 year. Despite different symptom profiles, RP and RT result in similar utility decrements.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19901935     DOI: 10.1038/pcan.2009.32

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  12 in total

1.  Trajectories and predictors of symptom occurrence, severity, and distress in prostate cancer patients undergoing radiation therapy.

Authors:  Katie Knapp; Bruce Cooper; Theresa Koetters; Janine Cataldo; Anand Dhruva; Steven M Paul; Claudia West; Bradley E Aouizerat; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2012-07-07       Impact factor: 3.612

2.  Measuring quality of life after radical prostatectomy from the patient's perspective.

Authors:  Joseph L Chin
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

3.  Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, Canada.

Authors:  Reka Pataky; Roman Gulati; Ruth Etzioni; Peter Black; Kim N Chi; Andrew J Coldman; Tom Pickles; Scott Tyldesley; Stuart Peacock
Journal:  Int J Cancer       Date:  2014-02-04       Impact factor: 7.396

4.  Differences in sleep disturbance and fatigue between patients with breast and prostate cancer at the initiation of radiation therapy.

Authors:  Kristin Garrett; Anand Dhruva; Theresa Koetters; Claudia West; Steven M Paul; Laura B Dunn; Bradley E Aouizerat; Bruce A Cooper; Marylin Dodd; Kathryn Lee; William Wara; Patrick Swift; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2011-03-31       Impact factor: 3.612

Review 5.  Robotic Surgical System for Radical Prostatectomy: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-07-07

6.  A reference set of health utilities for long-term survivors of prostate cancer: population-based data from Ontario, Canada.

Authors:  Murray D Krahn; Karen E Bremner; Shabbir M H Alibhai; Andy Ni; George Tomlinson; Audrey Laporte; Gary Naglie
Journal:  Qual Life Res       Date:  2013-04-06       Impact factor: 4.147

7.  The ProCaSP study: quality of life outcomes of prostate cancer patients after radiotherapy or radical prostatectomy in a cohort study.

Authors:  Nora Eisemann; Sandra Nolte; Maike Schnoor; Alexander Katalinic; Volker Rohde; Annika Waldmann
Journal:  BMC Urol       Date:  2015-04-10       Impact factor: 2.264

Review 8.  A Systematic Review and Meta-Analysis of Prostate Cancer Utility Values of Patients and Partners Between 2007 and 2016.

Authors:  Anne Magnus; Wanrudee Isaranuwatchai; Cathrine Mihalopoulos; Victoria Brown; Rob Carter
Journal:  MDM Policy Pract       Date:  2019-05-27

9.  Systematic Review of Cost-Effectiveness Models in Prostate Cancer: Exploring New Developments in Testing and Diagnosis.

Authors:  Edna Keeney; Howard Thom; Emma Turner; Richard M Martin; Josie Morley; Sabina Sanghera
Journal:  Value Health       Date:  2021-09-22       Impact factor: 5.725

10.  Different aspects of self-reported quality of life in 450 german melanoma survivors.

Authors:  Annika Waldmann; Sandra Nolte; Ron Pritzkuleit; Eckhard W Breitbart; Alexander Katalinic
Journal:  Cancers (Basel)       Date:  2011-05-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.